A new op-ed by Charles Sauer in the Washington Times argues that earlier Alzheimer’s diagnosis is not only a healthcare issue, but also a financial one for millions of American families. In the piece, Sauer explains how cognitive decline often begins affecting financial decision-making years before a formal diagnosis, leaving Read more…
Charles Sauer’s latest in RealClearPolicy warns that international organizations are quietly becoming de facto regulators — imposing costly environmental mandates without congressional approval. He argues that ISO’s push toward Scope 3 emissions tracking could raise prices, discourage investment, and hand advantages to foreign competitors like China. Outsourcing Emissions Policy Is Read more…
An op-ed by Market Institute President Charles Sauer in RealClearMarkets examines the growing push for government regulation of children’s social media use and argues that parents—not Washington—are best positioned to decide how and when their children engage online. Sauer discusses recent litigation involving Meta Platforms and Alphabet Inc., as well Read more…
A new op-ed by Charles Sauer in DC Journal makes a straightforward but often overlooked point: how goods move across the country directly affects what Americans pay at the checkout counter. Transportation costs are embedded in nearly every product. When those costs rise, prices follow. When they fall, the benefits Read more…
A new opinion piece by Charles Sauer in the The Washington Times takes a hard look at Zillow’s sudden embrace of “pre-market” listings—and finds something familiar. What Zillow is now branding as “Zillow Preview” isn’t new. It’s the same phased marketing strategy—often called private or “coming soon” listings—that the company Read more…
A new op-ed by Charles Sauer in RealClearMarkets raises a pointed—and uncomfortable—question: why are some Republicans embracing the very kinds of policies they once criticized for driving up prices? At a time when Washington claims to be focused on lowering costs, Sauer argues that policymakers risk repeating the same mistakes Read more…
In a recent piece for the Daily Caller, Charles Sauer highlights a growing disconnect between medical innovation and public policy when it comes to Alzheimer’s care—and the consequences could not be more serious. Health and Human Services Secretary Robert F. Kennedy Jr. recently put it plainly: “it is regulatory malpractice Read more…
Each year on April 26, World Intellectual Property Day offers an opportunity to reflect on the systems that help turn ideas into real-world impact. As Charles Sauer, Cori Kramer, and James Edwards explain, intellectual property protections remain central to innovation, economic growth, and opportunity in the United States and around Read more…
A new article by Market Institute Senior Fellow Norm Singleton in RealClearMarkets examines a troubling California jury verdict holding Meta and Alphabet liable for alleged harms tied to social media “addiction”—and warns of the broader consequences for innovation, free expression, and the future of the internet. A California jury recently Read more…
The House Energy and Commerce Committee’s Subcommittee on Health recently held a hearing examining the drivers of rising health care costs. While much of the discussion focused on consolidation among providers, a key cause of that consolidation received far less attention: the Section 340B drug pricing program. As Charles Sauer Read more…